포스터 다운로드_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

top

Please input keywords

KR

사회적 책임

합작연구개발

Antibody Assets

Project Integrum

Antibody discovery platforms

Clinical pipeline

Preclinical pipeline

동물/세포 모델

Humanized animal models

KO mouse models

Immunodeficient mice/rats

Disease mouse models

Pharmacology service

Therapeutic area

Types of services

유전자 편집

By technologies

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Microbial detection

Animal Breeding

Animal Cryopreservation

Animal Rederivation

Stock Information

Financial Reports

Listing Documents

Announcements & Notices

Corporate Governance

Investor Calendar

자료 다운로드

포스터 다운로드

홍보센터

뉴스 및 각종 자료 열람

논문게재실적

자료 다운로드

포스터 다운로드

제품정보 다운로드

AACR 2025: NKC and KIR humanized mice: a powerful tool to develop NK-targeting drugs

AACR 2025: Generation of humanized C1Q mice for antibody-mediated CDC therapy research

AACR 2025: The trispecific T cell engager platform enhances T cell function and therapeutic efficacy via integrated 4-1BB VHH antibody co-stimulation

AACR 2025: RenBiologics- a fully human antibody library generated by RenMice facilitates the development of antibody drugs

AACR 2025: Preclinical study of bispecific antibody drug conjugates (bsADCs) targeting DLL3 and SEZ6 demonstrated potent anti-tumor activity in small cell lung cancer (SCLC) xenograft models:

AACR 2025: Discovery of a highly potent fully human VEGF VHH antibody from RenNano transgenic mice that exhibits a superior blocking activity on VEGF function

AACR 2025: Development of fully human TCR-mimic antibodies targeting intracellular tumor antigens using humanized RenTCR-mimic transgenic mice

AACR 2025: Development of a human immune system reconstituted mouse model without the function of FcγRs expressed on mouse innate immune cells

AACR 2025: Development and validation of humanized HLA-A11.1 mouse model for preclinical evaluation of novel peptide vaccines

1 2 3 4 5 … 14